Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Fei‐Cheng Yang"'
Autor:
Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian, Yan Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-12 (2022)
Abstract Platelet-derived growth subunit A (PDGFA) plays critical roles in development of glioblastoma (GBM) with substantial evidence from TCGA database analyses and in vivo mouse models. So far, only platelet-derived growth receptor α (PDGFRA) has
Externí odkaz:
https://doaj.org/article/405264fc1e9d490c8dafcef11c97de0f
Autor:
Yue‐Liang Yao, Yan‐Xia Wang, Fei‐Cheng Yang, Chuan Wang, Min Mao, Qu‐Jing Gai, Jiang He, Yan Qin, Xiao‐Xue Yao, Xi Lan, Jiang Zhu, Hui‐Min Lu, Hui Zeng, Xiao‐Hong Yao, Xiu‐Wu Bian, Yan Wang
Publikováno v:
CNS Neuroscience & Therapeutics. 28:1033-1044
Sonic hedgehog subtype medulloblastoma is featured with overactivation of hedgehog pathway and can be targeted by SMO-specific inhibitors. However, the resistance is frequently developed leading to treatment failure of SMO inhibitors. W535L mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60478a69df89b1449b6a7c1994785d34
https://doi.org/10.1111/cns.13835
https://doi.org/10.1111/cns.13835
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fei-Cheng Yang, Chuan Wang, Jiang Zhu, Qu-Jing Gai, Min Mao, Jiang He, Yan Qin, Xiao-Xue Yao, Yan-Xia Wang, Hui-Min Lu, Mian-Fu Cao, Ming-Min He, Xian-Mei Wen, Ping Leng, Xiong-Wei Cai, Xiao-Hong Yao, Xiu-Wu Bian, Yan Wang
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 102(7)
Invasive growth of glioblastoma makes residual tumor unremovable by surgery and leads to disease relapse. Temozolomide is widely used first-line chemotherapy drug to treat glioma patients, but development of temozolomide resistance is almost inevitab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4ed85aefab8e79129ce179f90a3fa7
https://pubmed.ncbi.nlm.nih.gov/35351965
https://pubmed.ncbi.nlm.nih.gov/35351965
Publikováno v:
Oncology Letters. 14:1080-1088
Triple-negative breast cancer (TNBC; estrogen receptor-negative, progesterone receptor-negative and Her-2-negative) is often accompanied by a higher frequency of p53 gene mutations. Therefore, TNBC is challenging to treat due to a lack of biological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6dcf49f08326f8d8a6dda7d143b22d6
https://doi.org/10.3892/ol.2017.6273
https://doi.org/10.3892/ol.2017.6273
Autor:
Lan-Zhen, Huang, Juan, Wang, Fei-Ting, Lu, Fei-Cheng, Yang, Xu, Chen, Xue, Hong, Xiao-Shan, Jiang
Publikováno v:
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica. 38(11)
To investigate the anti-proliferative effects of curcumol, an herbal extract from curcuma, in human hepatocarcinoma HepG2 cells, and its possible molecular mechanism.The effects of curcumol on human hepatocarcinoma cells were assessed in vitro. Proli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a40191a07096f7137bd85bbbf14422fe
https://pubmed.ncbi.nlm.nih.gov/24010301
https://pubmed.ncbi.nlm.nih.gov/24010301